HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M M Samama Selected Research

M M Samama Research Topics

Disease

9Venous Thromboembolism
06/2011 - 07/2000
5Thrombocytopenia (Thrombopenia)
02/2011 - 05/2000
4Hemorrhage
10/2013 - 02/2002
4Thrombosis (Thrombus)
02/2011 - 03/2000
3Atrial Fibrillation
10/2013 - 02/2011
3Venous Thrombosis (Deep-Vein Thrombosis)
11/2005 - 10/2001
3Neoplasms (Cancer)
03/2005 - 11/2000
2Thrombophilia
11/2005 - 06/2002
2Activated Protein C Resistance (APC Resistance)
07/2002 - 01/2001
1Stroke (Strokes)
06/2011
1Acute Coronary Syndrome
02/2011
1von Willebrand Diseases (von Willebrand's Disease)
04/2006
1Congenital Abnormalities (Deformity)
03/2005
1Coronary Thrombosis
11/2002
1Body Weight (Weight, Body)
06/2002
1Postoperative Pain
02/2002
1Acute Kidney Injury (Acute Renal Failure)
02/2002
1Hypersensitivity (Allergy)
02/2002
1Pain (Aches)
02/2002
1Inflammation (Inflammations)
01/2001
1Thrombocytosis (Thrombocythemia)
01/2001
1Heart Failure
12/2000
1Venous Insufficiency
12/2000
1Obesity
12/2000
1Communicable Diseases (Infectious Diseases)
12/2000
1Hematologic Neoplasms (Hematological Malignancy)
12/2000
1Wounds and Injuries (Trauma)
12/2000
1Myocardial Infarction
07/2000

Drug/Important Bio-Agent (IBA)

8AnticoagulantsIBA
10/2013 - 09/2001
5Heparin (Liquaemin)FDA LinkGeneric
02/2011 - 05/2000
3ThrombinFDA Link
10/2013 - 01/2001
2Pharmaceutical PreparationsIBA
10/2013 - 12/2000
2fibrin fragment D (D-dimer)IBA
11/2005 - 12/2003
2Biological ProductsIBA
03/2005 - 11/2000
1Factor IIaIBA
10/2013
1N(4)-oleylcytosine arabinosideIBA
10/2013
1RivaroxabanIBA
10/2013
1DabigatranFDA Link
10/2013
1Factor Xa InhibitorsIBA
10/2013
1edoxabanIBA
06/2011
1Factor Xa (Coagulation Factor Xa)IBA
06/2011
1RistocetinIBA
04/2006
1Factor VIII (Coagulation Factor VIII)IBA
04/2006
1von Willebrand FactorIBA
04/2006
1Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
03/2005
1Vitamin KFDA Link
03/2005
1Dalteparin (Dalteparin Sodium)FDA Link
03/2005
1Biomarkers (Surrogate Marker)IBA
11/2002
1Protein CIBA
07/2002
1Prothrombin (Factor II)IBA
07/2002
1factor V LeidenIBA
07/2002
1Ketoprofen (Orudis)FDA LinkGeneric
02/2002
1Diclofenac (SR 38)FDA LinkGeneric
02/2002
1KetorolacIBA
02/2002
1AntibodiesIBA
10/2001
1Platelet Factor 4IBA
10/2001
1Thromboplastin (Tissue Factor)IBA
01/2001
1Fibrin Fibrinogen Degradation ProductsIBA
01/2001
1cancer procoagulantIBA
01/2001
1Antiphospholipid AntibodiesIBA
01/2001
1Fibrinopeptide AIBA
01/2001
1lipoprotein-associated coagulation inhibitor (TFPI)IBA
01/2001
1Fibrinogen (Factor I)FDA Link
01/2001
1Blood Coagulation Factors (Coagulation Factor)IBA
01/2001
1AntithrombinsIBA
01/2001
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
03/2000

Therapy/Procedure

2Therapeutics
11/2005 - 07/2000
2Orthopedic Procedures
03/2005 - 11/2004
2Duration of Therapy
06/2002 - 02/2002
1Subcutaneous Injections
06/2002
1Secondary Prevention
10/2001
1Surgical Casts (Plaster Cast)
12/2000
1Operative Surgical Procedures
07/2000